Page last updated: 2024-09-03

3-(2,4-dimethoxybenzylidene)anabaseine and Experimental Lung Inflammation

3-(2,4-dimethoxybenzylidene)anabaseine has been researched along with Experimental Lung Inflammation in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hoedemaekers, CW; Kox, M; Peters, E; Pickkers, P; Pompe, JC; Scheffer, GJ; van der Hoeven, JG; van der Laak, JW; Vaneker, M1

Other Studies

1 other study(ies) available for 3-(2,4-dimethoxybenzylidene)anabaseine and Experimental Lung Inflammation

ArticleYear
α7 nicotinic acetylcholine receptor agonist GTS-21 attenuates ventilator-induced tumour necrosis factor-α production and lung injury.
    British journal of anaesthesia, 2011, Volume: 107, Issue:4

    Topics: Acute Lung Injury; alpha7 Nicotinic Acetylcholine Receptor; Animals; Benzylidene Compounds; Cholinesterase Inhibitors; Interleukin-10; Lipopolysaccharides; Male; Mecamylamine; Mice; Mice, Inbred C57BL; Neostigmine; Neutrophil Infiltration; Nicotinic Agonists; Nicotinic Antagonists; Pneumonia; Pulmonary Alveoli; Pyridines; Receptors, Nicotinic; Respiration, Artificial; Tumor Necrosis Factor-alpha; Ventilator-Induced Lung Injury

2011